Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis
β Scribed by A. E. van der Bijl; Y. P. M. Goekoop-Ruiterman; J. K. de Vries-Bouwstra; S. ten Wolde; K. H. Han; M. V. van Krugten; C. F. Allaart; F. C. Breedveld; B. A. C. Dijkmans
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 109 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (antiβtumor necrosis factor Ξ± [antiβTNFΞ±] monoclonal antibody) with those of MTX treatment alone in patients with rheumatoid arthritis (RA) of β€3 years' duration. ## Methods RA patient
## Abstract ## Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000 incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per 100,000 persons. Recently, reports of TB following infliximab administration have raised questions